Home
Chemkart India Ltd Share Price History
Chemkart India Ltd
BSE : 31 Dec, 2026
128.45-2.1 (-1.6%)
Prev Close
130.6
Open Price
125.1
Bid Price (QTY)
-
Offer Price (QTY)
-
Volume
37800
Today's High / Low
130.2 / 124.6
52 WK High / Low
262.0 / 104.0
Market Price of Chemkart India Ltd
1M
1Y
3Y
5Y
Monitoring Chemkart India Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.
History Market Price
| Date | Price | Open | High | Low |
|---|
Returns Comparison
1W
1M
3M
6M
1Y
3Y
5Y
10Y
Growth Parameters
| Parameter |  2022 |
|---|---|
| Sales (Cr.) | NaN |
| Sales YoY Gr. | - |
| Adj EPS | 40.38 |
| YoY Gr. | - |
| Net Profit (Cr.) | 5 |
| BVPS | 50.38 |
Key Financial Parameters
| Parameter | 2022 |
|---|---|
| Return on Capital Emp. % | 59.63 |
| Op. Profit Mgn % | 8.59 |
| Net Profit Mgn % | 6.3 |
| Debt to Equity % | 0.83 |
Latest Shareholding
Promoters Holdings Over Time
About Chemkart India Ltd
- Chemkart India Limited was established on March 06, 2020 as 'Chemkart India Private Limited', a private limited company pursuant to a certificate of incorporation dated March 06, 2020 issued by Deputy Registrar of Companies.
- Further, Company was converted into a public limited company and the name was changed to Chemkart India Limited' and a fresh certificate of incorporation dated October 04, 2024 was issued by Registrar of Companies, Central Processing Centre. The Company is mainly engaged in the business of Processing and Trading of Nutritional and Health Supplements.
- It offer products across seven product categories, i.e.
- Amino Acids, Health Supplement, Herbal Extract, Nucleotide, Protein, Sports Nutrition, and Vitamin.
- The Company also engages actively with their suppliers to improve the supply chain processes.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
